Recurrent Pneumocystis carinii colonization in a heart-lung transplant recipient on long-term trimethoprim-sulfamethoxazole prophylaxis

J Heart Lung Transplant. 1999 Apr;18(4):384-7. doi: 10.1016/s1053-2498(98)00038-2.

Abstract

Introduction: In the setting of organ transplantation, prior to prophylaxis, Pneumocystis carinii pneumonia (PCP) had been a common clinical problem, particularly in heart-lung and lung recipients who receive long-term immunosuppressive therapy to prevent allograft rejection. Continuous oral trimethoprim-sulfamethoxazole (TMP-SMX) has been highly effective in preventing PCP in these patients.

Report: In this paper we report a case of recurrent Pneumocystis carinii infection in a chronic (> 15 years) heart-lung allograft recipient on long-term TMP-SMX prophylaxis. Twice, in 1995 and again in 1998, Pneumocystis carinii infection was diagnosed by bronchoalveolar lavage (BAL), in the same patient, despite continued oral TMP-SMX (960 mg TMP/4800 mg SMX per week) prophylaxis. The subject was not lymphopenic (his CD4 count was 569/mm3) and there was no associated deterioration in pulmonary function, nor evidence of hypoxemia.

Conclusion: This case demonstrates that asymptomatic Pneumocystis carinii lung infections may recur in chronic heart-lung transplant recipients who take standard oral PCP prophylaxis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Bronchoalveolar Lavage Fluid / microbiology
  • CD4 Lymphocyte Count
  • Clindamycin / therapeutic use
  • Forced Expiratory Volume / physiology
  • Heart-Lung Transplantation*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Opportunistic Infections / diagnosis*
  • Pneumocystis / growth & development
  • Pneumocystis Infections / diagnosis*
  • Pulmonary Gas Exchange / physiology
  • Recurrence
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*
  • Vital Capacity / physiology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Immunosuppressive Agents
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination